Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Sanofi Consumer Healthcare India Ltd. is lagging significantly behind its peers in key financial metrics including profitability, efficiency, and growth. With no revenue growth or profitability indicators, it is classified as financially weak, while its peers exhibit stronger financial health and growth potential.
Strong revenue growth (13.28% YoY) and attractive PE ratio (23.73) with solid profitability metrics.
Highest EPS (45.55), strong revenue growth (8.42% YoY), and robust ROE (16.13%).
Solid profitability metrics with high ROE (21.76%) and revenue growth (16.54% YoY).